Neha Kanojia
Associate Consultant (Patient Centered Solution)- Life Science Strategy @IQVIA
Signup · Get unlimited contacts
WORK HISTORY
Associate Consultant (Patient Centered Solution)- Life Science Strategy @IQVIA
Bengaluru, IN
Support global pharmaceutical clients on patient-centered evidence strategy, including COA selection, development, and validation-Contribute to PRO, HRQoL, and endpoint strategy aligned with regulatory and payer expectations-Develop Target Labeling Concepts (TLCs) and patient-focused evidence frameworks-Translate clinical and patient data into strategic, client-ready insights for regulatory and commercial decision-making-Collaborate with cross-functional IQVIA teams across strategy, evidence, and medical domainsKey domains: Patient-Centered Outcomes (PCS)| Clinical Outcome Assessments (COA)| Patient-Reported Outcomes (PRO)| Health-Related Quality of Life (HRQoL)| Life Sciences Consulting & Evidence Generation | Regulatory Strategy (FDA/EMA/other payers)| Market Access Strategy | Scientific & Medical Writing | Healthcare Strategy |
EDUCATION
Institute of genomics and integrative biology (CSIR)
Doctor of Philosophy - PhD, Pharmacogenomics/Biological Sciences/Life Sciences/Molecular Pharmacology
University of Delhi
B.Sc (H), BIOMEDICAL SCIENCES
University of Delhi
Master's degree, Biological and Biomedical Sciences ( Dr. B.R. Ambedkar Centre for Biomedical Research (ACBR))
ABOUT NEHA KANOJIA
I am a Life Sciences Strategy Consultant within IQVIA’s Patient-Centered Solutions (PCS) team, specializing in the integration of patient-centered evidence into clinical development, regulatory strategy, and market access decision-making.With 9+ years of combined experience across academic research and the healthcare industry, I support global pharmaceutical and biotech clients in the development, validation, and strategic positioning of Clinical Outcome Assessments (COAs), including PRO, ClinRO, and ObsRO instruments led by patient experience data (PED).In my current role at IQVIA, I contribute to-COA strategy development aligned with regulatory and payer expectations-Target Labeling Concepts (TLCs) and endpoint strategy-Patient-focused drug development and evidence generation-Scientific and strategic deliverables for global pharma clientsPrior to IQVIA, I led technical operations and product development initiatives within a biotech start-up, managing IVD development, regulatory documentation, audits, and cross-functional stakeholder engagement.I bring a PhD-driven scientific foundation in molecular biology and pharmacogenomics, with peer-reviewed publications across oncology, neurology, and neuro-endocrinology, and a strong ability to translate complex science into clear, decision-ready insights for both scientific and commercial audiences. Core strengths: PCS consulting | COA & PRO strategy | Patient-centered evidence | Regulatory-aligned storytelling | Life sciences strategy Industry focus: Pharmaceuticals, biotech, diagnostics What drives me: Delivering evidence that meaningfully reflects patient experience and supports better healthcare decisions
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.